Greetings!

Today we're hosting our Friday afternoon member call on COVID-19 at 3:30 pm. The link to access the call series has not changed and is included below for your convenience.
 
This update also includes:
  • the instructions from DMAS on the CARES Act Funding (Steve Ford will review this on the call);
  • info on the CDC interim guidance on rapid antigen tests.

We look forward to talking with everyone at 3:30 pm.

Sincerely,

April Payne, LNHA
Vice President of Quality Improvement | Director of VCAL
Virginia Health Care Association | Virginia Center for Assisted Living 
VHCA-VCAL Member Call: COVID-19
August 21, 2020 | 3:30 pm
 
Register for the meeting:

After registering, you will receive a confirmation email containing information about joining the meeting, including calendar notices for future calls.

Agenda
  1. Welcome | Novel Martin | Chairman
  2. VHCA-VCAL Updates | Keith Hare | President and CEO
  3. Funding Update | Steve Ford | Senior Vice President for Policy and Reimbursement
  4. Hot Topic Review | April Payne | Vice President of Quality Improvement and Director of VCAL

Please mute your line to improve the sound quality on the call. Zoom has a chat feature you can use to send questions or comments.
DMAS Instructions on CARES Act Funding
for NFs and ALFs

DMAS has issued instructions on how NFs and ALFs can access the $33 million and $20 million, respectively, in CARES Act funding distributed by Virginia. The program provides funds to cover expenses incurred due to the coronavirus pandemic for the period from July 1, 2020 through October 31, 2020.

In June, Gov. Ralph Northam announced Virginia will use federal CARES Act funding to support licensed NFs and ALFs in the Commonwealth with unreimbursed COVID-19 costs. Funding can be used to reimburse spending on staffing shortages, increasing infection control measures, purchasing personal protective equipment, and other demonstrated COVID-19 costs. To receive reimbursement through this CARES Act funded program, facilities must first offset any other revenues specifically provided for COVID-19 expenses. For NFs this includes federal Provider Relief Funding, Virginia $20 per diem, etc.

Keep in mind that VHCA-VCAL is attempting to modify the program rules through the General Assembly action. Most notably for NFs, DMAS will not recognize lost revenue as a legitimate COVID-expense neither for this funding, nor for the direct provider relief you have received directly from the CARES Act. In other words, if you use the direct provider relief for lost revenue, it will not be considered “spent” for purposes of accessing this new funding. Unless that changes, we are recommending that invoices should not be submitted unless they show eligible unreimbursed “direct” costs above the amount of your lost revenue.

DMAS has been designated as the responsible agency to implement the program. For more information, please review the following documents:

--The enrollment form for eligible providers—both NF and ALFs: 
 
--Letters detailing eligible expenses, enrollment requirements, maximum reimbursement, and relevant deadlines:

--The required invoice workbooks that must be submitted with supporting documentation for reimbursement. You will need to download the appropriate invoice file (there are separate files for NFs and ALFs), which are posted on the DMAS COVID-19 Response webpage. Scroll to find the yellow “Support for Providers” icon and look for the files called:
  • CARES Act Invoice Workbook with Instructions for Nursing Facilities [xlsx]
  • CARES Act Invoice Workbook with Instructions for Assisted Living Facilities [xlsx]

Specific questions from providers should be directed to MSLC at [email protected].
CDC Interim Guidance on Rapid Antigen Tests
 
This week, the CDC released new interim guidance on rapid antigen testing for COVID-19. The key points that members should be aware of include:

  • The two rapid antigen tests on the market (BD Veritor and Quidel Sofia2, which are being sent to all nursing homes by CMS) are currently intended for use in diagnostic testing of symptomatic patients within five days of symptom onset.
  • Through this new guidance, CDC expands use of these rapid antigen tests to include use as screening tool in congregate settings (such as a nursing home) for staff and residents.
  • All long term care facilities must defer to state or local guidance on their use. As a reminder, VDH has issued this interim guidance.
  • Evaluating the test results must be done in context with the person’s symptoms and how likely COVID-19 is in the group of people getting the tests, which is usually similar to the community’s rate of COVID-19. 
  • Providers who are utilizing these antigen test devices must undergo proper training and be able to demonstrate competency and completion.

It is very important that providers who are utilizing the point of care antigen test device understand this new CDC guidance. AHCA/NCAL has developed a more comprehensive summary here that members can utilize.

AHCA/NCAL has also added information on how to access training for both antigen devices (BD Veritor and Quidel Sofia2) to its summary of important steps providers must take in preparing to use these testing devices.

Additionally, CMS is expected to update the list of nursing homes receiving the point-of-care (POC) antigen tests as of Thursday, August 20. CMS provides a zip file (an excel file) with the names of all the nursing homes to receive either the Quidel Sophia-2 or BD POC antigen tests. You can also find this list on Data.CMS.gov under the paragraph “Supporting COVID-19 Testing.”
Upcoming Events

August 25, 2020 | 1:00 – 2:00 pm

August 26, 2020 | 2:00 pm

September 13-19, 2020

2020 Virtual Convention and Trade Show
September 29 – October 29, 2020 *Save the Dates*
Quick Links
www.vhca.org | (804) 353-9101 | Calendar of Events